Medication info
Ospurus D Tablet

Ospurus D Tablet

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
White to pale gray oblong tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201207585 · Approved 2012.10.31 · Insurance code 649506190

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine once weekly (70 mg/2800 IU or 70 mg/5600 IU) in the morning, with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been determined. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be regularly reassessed for fracture risk. Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption and decrease its effect. This medicine should be taken as soon as you get up in the morning and swallowed with plenty of water (170∼230 mL) to ensure rapid passage of the medicine to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking the medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General precautions”). Patients whose dietary intake of calcium and vitamin D is inadequate should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to be provided to patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, institutionalized patients, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a one-week supply of 400 IU or 800 IU of vitamin D per day. If a patient taking 1 tablet of this medicine misses a dose on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal failure (creatinine clearance 35∼60 mL/min); however, administration is not recommended in patients with severe renal failure (creatinine clearance below 35 mL/min) because clinical experience is insufficient.
Child dose
Children and adolescents (under 18 years): Safety and efficacy have not been established in children and adolescents.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine once weekly (70 mg/2800 IU or 70 mg/5600 IU) in the morning, with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been determined. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be regularly reassessed for fracture risk. Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption and decrease its effect. This medicine should be taken as soon as you get up in the morning and swallowed with plenty of water (170∼230 mL) to ensure rapid passage of the medicine to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking the medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General precautions”). Patients whose dietary intake of calcium and vitamin D is inadequate should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to be provided to patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, institutionalized patients, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a one-week supply of 400 IU or 800 IU of vitamin D per day. If a patient taking 1 tablet of this medicine misses a dose on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal failure (creatinine clearance 35∼60 mL/min); however, administration is not recommended in patients with severe renal failure (creatinine clearance below 35 mL/min) because clinical experience is insufficient.

Child dose

Children and adolescents (under 18 years): Safety and efficacy have not been established in children and adolescents.

Precautions

This medication may irritate the mucosa of the upper gastrointestinal tract, leading to issues such as esophagitis, esophageal ulcers, and esophageal erosion. In severe cases, it could cause esophageal obstruction or perforation, so if symptoms such as dysphagia, odynophagia, pain behind the sternum, or heartburn occur during use, stop taking it and consult a doctor. This medication must be taken with plenty of water and should not lie down for at least 30 minutes after taking it. Patients with difficulty in esophageal clearance, those who cannot sit or stand upright for at least 30 minutes, patients with allergies to any component of this medication, patients with hypocalcemia, or those with certain genetic metabolic disorders should not take this medication. While taking this medication, gastrointestinal-related symptoms such as abdominal pain, nausea, dyspepsia, constipation, diarrhea, gastric acid reflux, and esophagitis may occur, along with musculoskeletal pain, headache, dizziness, and taste alteration. Taking this medication with calcium supplements or antacids can hinder absorption, so a minimum interval of at least 30 minutes should be maintained. Additionally, caution should be exercised when used in conjunction with aspirin or non-steroidal anti-inflammatory drugs, as gastrointestinal side effects may increase. During pregnancy, there is a potential risk to the fetus, so it should only be used when absolutely necessary; during breastfeeding, it should also be used cautiously. This medication is not to be used in children, and special caution is required for elderly patients or those with severely impaired kidney function. In case of overdose, symptoms such as hypocalcemia or gastrointestinal irritation may appear, and immediate consultation with a healthcare professional is necessary; inducing vomiting should be avoided, and the patient should be kept upright. This medication should be stored out of reach of children, and transferring to another container could lead to degradation of quality or accidents, so caution is advised.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 44 more
  • abdominal pain
  • nausea
  • indigestion
  • constipation
  • diarrhea
  • flatulence
  • acid reflux
  • vomiting
  • abdominal bloating
  • gastritis
  • musculoskeletal pain
  • muscle cramps
  • headache
  • dizziness
  • taste disorders
  • rash
  • erythema
  • anastomotic ulcer
  • urticaria
  • angioedema
  • myalgia
  • malaise
  • asthenia
  • fever
  • symptoms of hypocalcemia
  • peripheral edema
  • oropharyngeal ulcer
  • gastric ulcer
  • duodenal ulcer
  • osteomyelitis
  • jaw necrosis
  • joint swelling
  • low-grade fracture
  • dizziness
  • vertigo
  • itching
  • hair loss
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • uveitis
  • scleritis
  • episcleritis
  • external auditory canal cholesteatoma
  • nasopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Also, it is important to avoid direct sunlight and store it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White to pale gray oblong tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.